Trial Outcomes & Findings for Opioid-free Analgesia for the Management of Acute Post-operative Pain Following Caesarean Section (NCT NCT04539249)

NCT ID: NCT04539249

Last Updated: 2023-07-20

Results Overview

Post-operative pain scores following caesarean section at 4 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

324 participants

Primary outcome timeframe

4 hours post-operative

Results posted on

2023-07-20

Participant Flow

A total of 324 participants were enrolled and assessed for eligibility. A total of 224 of the enrolled participants were excluded from the study. Of the 224, one (1) declined to participate while the rest 223 did not meet the inclusion criteria.

Participant milestones

Participant milestones
Measure
Magnesium Sulphate
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Overall Study
STARTED
50
50
Overall Study
Allocation
50
50
Overall Study
Intervention Per Protocol
49
50
Overall Study
Intervention NOT Per Protocol
1
0
Overall Study
Analyzed
50
50
Overall Study
Excluded From Analysis
0
0
Overall Study
COMPLETED
50
50
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Opioid-free Analgesia for the Management of Acute Post-operative Pain Following Caesarean Section

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Total
n=100 Participants
Total of all reporting groups
Age, Continuous
31.7 years
STANDARD_DEVIATION 3.4 • n=5 Participants
30.8 years
STANDARD_DEVIATION 4.3 • n=7 Participants
31.3 years
STANDARD_DEVIATION 3.9 • n=5 Participants
Age, Customized
20-24
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Customized
25-29
12 Participants
n=5 Participants
19 Participants
n=7 Participants
31 Participants
n=5 Participants
Age, Customized
30-34
25 Participants
n=5 Participants
16 Participants
n=7 Participants
41 Participants
n=5 Participants
Age, Customized
35-39
13 Participants
n=5 Participants
14 Participants
n=7 Participants
27 Participants
n=5 Participants
Sex: Female, Male
Female
50 Participants
n=5 Participants
50 Participants
n=7 Participants
100 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Igbo
21 Participants
n=5 Participants
18 Participants
n=7 Participants
39 Participants
n=5 Participants
Race/Ethnicity, Customized
Ijaw
23 Participants
n=5 Participants
20 Participants
n=7 Participants
43 Participants
n=5 Participants
Race/Ethnicity, Customized
Others
6 Participants
n=5 Participants
12 Participants
n=7 Participants
18 Participants
n=5 Participants
Region of Enrollment
Nigeria
50 participants
n=5 Participants
50 participants
n=7 Participants
100 participants
n=5 Participants
Weight
84.5 Kilograms
STANDARD_DEVIATION 12.8 • n=5 Participants
77.9 Kilograms
STANDARD_DEVIATION 8.9 • n=7 Participants
81.2 Kilograms
STANDARD_DEVIATION 11.5 • n=5 Participants
Parity
Nulliparous (Never carried a pregnancy up to 28 weeks gestation or beyond)
6 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
Parity
Primiparous (Carried one (1) pregnancy up to 28 weeks and beyond, irrespective of outcome)
11 Participants
n=5 Participants
6 Participants
n=7 Participants
17 Participants
n=5 Participants
Parity
Multiparous (Carried two (2) or more pregnancies up to 28 weeks and beyond, irrespective of outcome)
33 Participants
n=5 Participants
33 Participants
n=7 Participants
66 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 hours post-operative

Post-operative pain scores following caesarean section at 4 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Post-operative Pain Scores Following Caesarean Section at 4 Hours Post-operative
2.98 score on a scale
Standard Deviation 1.18
3.16 score on a scale
Standard Deviation 1.45

PRIMARY outcome

Timeframe: 8 hours post-operative

Post-operative pain scores following caesarean section at 8 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Post-operative Pain Scores Following Caesarean Section at 8 Hours Post-operative
2.58 score on a scale
Standard Deviation 1.81
2.68 score on a scale
Standard Deviation 1.63

PRIMARY outcome

Timeframe: 24 hours post-operative

Post-operative pain scores following caesarean section at 24 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Post-operative Pain Scores Following Caesarean Section at 24 Hours Post-operative
2.06 score on a scale
Standard Deviation 1.42
2.37 score on a scale
Standard Deviation 1.54

PRIMARY outcome

Timeframe: 24 hours post-operative

Whether or not Pentazocine was used post-operatively

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Post-operative Pentazocine Use
Pentazocine used
46 Participants
50 Participants
Post-operative Pentazocine Use
Pentazocine NOT used
4 Participants
0 Participants

PRIMARY outcome

Timeframe: 24 hours post-operative

Whether or not pentazocine was used as rescue analgesia

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Pentazocine Use as Rescue Analgesia
Pentazocine used as rescue analgesia
46 Participants
0 Participants
Pentazocine Use as Rescue Analgesia
Pentazocine NOT used as rescue analgesia
4 Participants
50 Participants

PRIMARY outcome

Timeframe: 24 hours post-operative

Frequency of Pentazocine use per participant in each arm of the study and whether it was used as indicated in the protocol and/or for rescue analgesia

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Frequency and Nature of Pentazocine Use
Four times (as rescue analgesia)
0 Participants
0 Participants
Frequency and Nature of Pentazocine Use
Three times (as rescue analgesia)
0 Participants
0 Participants
Frequency and Nature of Pentazocine Use
Two times (as rescue analgesia)
11 Participants
0 Participants
Frequency and Nature of Pentazocine Use
Once (as rescue analgesia)
35 Participants
0 Participants
Frequency and Nature of Pentazocine Use
More than 4 times (per protocol + as rescue analgesia)
0 Participants
0 Participants
Frequency and Nature of Pentazocine Use
Four times (per protocol)
0 Participants
50 Participants
Frequency and Nature of Pentazocine Use
Not used at all
4 Participants
0 Participants

PRIMARY outcome

Timeframe: 24 hours post-operative

Mean dose of Pentazocine used in each arm of the study

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Mean Dose of Pentazocine Used
52.83 Milligrams
Standard Deviation 21.85
164.40 Milligrams
Standard Deviation 28.59

SECONDARY outcome

Timeframe: Time of first administration of peri-operative analgesia to 2 hours postoperative

Population: Number analyzed under severe (symptomatic) systolic hypotension (n=14; MgSo4 arm, n=5; Pentazocine arm ) and under severe (symptomatic) diastolic hypotension (n=24; MgSo4 arm, n=18; Pentazocine arm ) are subsets of the outcome measures systolic hypotension and diastolic hypotension with participant counts of (n=14; MgSo4 arm, n=5; Pentazocine arm ) and (n=24; MgSo4 arm, n=18; Pentazocine arm ) respectively

Number of participants with peri-operative adverse events including hypersensitivity reaction, respiratory depression, bradycardia, hypotension, nausea and vomiting, lightheadedness, presyncope, and any other adverse event recorded from the time of first administration of peri-operative analgesia to 2 hours postoperative

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Number of Participants With Peri-operative Adverse Events
Systolic hypotension · Present
14 Participants
5 Participants
Number of Participants With Peri-operative Adverse Events
Systolic hypotension · Absent
36 Participants
45 Participants
Number of Participants With Peri-operative Adverse Events
Severe (Symptomatic) diastolic hypotension · Present
1 Participants
0 Participants
Number of Participants With Peri-operative Adverse Events
Severe (Symptomatic) diastolic hypotension · Absent
23 Participants
18 Participants
Number of Participants With Peri-operative Adverse Events
Bradycardia · Present
0 Participants
2 Participants
Number of Participants With Peri-operative Adverse Events
Bradycardia · Absent
50 Participants
48 Participants
Number of Participants With Peri-operative Adverse Events
Severe (Symptomatic) systolic hypotension · Present
1 Participants
0 Participants
Number of Participants With Peri-operative Adverse Events
Severe (Symptomatic) systolic hypotension · Absent
13 Participants
5 Participants
Number of Participants With Peri-operative Adverse Events
Diastolic hypotension · Present
24 Participants
18 Participants
Number of Participants With Peri-operative Adverse Events
Diastolic hypotension · Absent
26 Participants
32 Participants
Number of Participants With Peri-operative Adverse Events
Vomiting · Present
1 Participants
0 Participants
Number of Participants With Peri-operative Adverse Events
Vomiting · Absent
49 Participants
50 Participants
Number of Participants With Peri-operative Adverse Events
Lightheadedness · Present
1 Participants
0 Participants
Number of Participants With Peri-operative Adverse Events
Lightheadedness · Absent
49 Participants
50 Participants
Number of Participants With Peri-operative Adverse Events
Presyncope · Present
1 Participants
0 Participants
Number of Participants With Peri-operative Adverse Events
Presyncope · Absent
49 Participants
50 Participants

SECONDARY outcome

Timeframe: First 24 hours post-operative

Number of participants with post-operative adverse events including respiratory depression constipation, ileus, pruritus, urinary retention and any other adverse event recorded during the first 24 hours post-operative.

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=4 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=46 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
n=50 Participants
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Number of Participants With Post-operative Adverse Events
Absent
4 Participants
46 Participants
50 Participants
Number of Participants With Post-operative Adverse Events
Present
0 Participants
0 Participants
0 Participants

SECONDARY outcome

Timeframe: At first and fifth minutes after birth

Apgar scores of the neonates delivered by the women who had caesarean section under the study, taken at first and fifth minutes after birth. Apgar score has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a better outcome (0-3= low Apgar score, 4-6= moderately abnormal Apgar score and 7-10= reassuring Apgar score

Outcome measures

Outcome measures
Measure
Magnesium Sulphate
n=50 Participants
Combination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac Magnesium sulphate: 1g of paracetamol as an I.V infusion and 4g of magnesium sulphate as an I.V. bolus preoperatively. Continuous infusion of 1g/hr of magnesium sulphate intraoperatively and for the first 2 hours post-operatively. Further post-operatively, 100 mg of suppository diclofenac 12 hourly, intravenous paracetamol 1g 6 hourly, both over 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine
n=50 Participants
Combination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac Pentazocine: Post-operatively, suppository diclofenac 100mg 12 hourly, intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) 6 hourly, intravenous paracetamol 1g 6 hourly, all for 24 hours. N.B: Intramuscular pentazocine 30 mg (45 mg if patient is \> 70 kg) will be used as rescue analgesia as needed (that is, only on patients' request for further analgesia or following an assessment of moderate to severe pain despite the planned analgesic regimen) at least 4 hourly during the first 24 hours after caesarean section.
Pentazocine Only
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Apgar Scores of the Neonates
Apgar score at the 5th minute · Less than 4
0 Participants
1 Participants
Apgar Scores of the Neonates
Apgar score at the 1st minute · Less than 4
0 Participants
0 Participants
Apgar Scores of the Neonates
Apgar score at the 1st minute · 4-6
2 Participants
6 Participants
Apgar Scores of the Neonates
Apgar score at the 1st minute · 7-10
48 Participants
44 Participants
Apgar Scores of the Neonates
Apgar score at the 5th minute · 4-6
0 Participants
0 Participants
Apgar Scores of the Neonates
Apgar score at the 5th minute · 7-10
50 Participants
49 Participants

Adverse Events

Magnesium Sulphate Only

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Magnesium Sulphate and Pentazocine

Serious events: 1 serious events
Other events: 19 other events
Deaths: 0 deaths

Pentazocine Only

Serious events: 0 serious events
Other events: 20 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Magnesium Sulphate Only
n=4 participants at risk
.Participants in the magnesium sulphate arm of the study who received a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac, but DID NOT receive post-operative intramuscular pentazocine as rescue analgesia
Magnesium Sulphate and Pentazocine
n=46 participants at risk
Participants in the magnesium sulphate arm of the study who received a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac, and ALSO received post-operative intramuscular pentazocine as rescue analgesia
Pentazocine Only
n=50 participants at risk
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Cardiac disorders
Severe (symptomatic) hypotension
0.00%
0/4 • Pre-operative, intra-operative and first 24 hours post-operative
2.2%
1/46 • Number of events 1 • Pre-operative, intra-operative and first 24 hours post-operative
0.00%
0/50 • Pre-operative, intra-operative and first 24 hours post-operative

Other adverse events

Other adverse events
Measure
Magnesium Sulphate Only
n=4 participants at risk
.Participants in the magnesium sulphate arm of the study who received a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac, but DID NOT receive post-operative intramuscular pentazocine as rescue analgesia
Magnesium Sulphate and Pentazocine
n=46 participants at risk
Participants in the magnesium sulphate arm of the study who received a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac, and ALSO received post-operative intramuscular pentazocine as rescue analgesia
Pentazocine Only
n=50 participants at risk
Participants in the pentazocine arm of the study who received a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Cardiac disorders
Mild (asymptomatic) systolic hypotension
0.00%
0/4 • Pre-operative, intra-operative and first 24 hours post-operative
0.00%
0/46 • Pre-operative, intra-operative and first 24 hours post-operative
10.0%
5/50 • Number of events 5 • Pre-operative, intra-operative and first 24 hours post-operative
Cardiac disorders
Mild (asymptomatic) diastolic hypotension
100.0%
4/4 • Number of events 4 • Pre-operative, intra-operative and first 24 hours post-operative
41.3%
19/46 • Number of events 19 • Pre-operative, intra-operative and first 24 hours post-operative
36.0%
18/50 • Number of events 18 • Pre-operative, intra-operative and first 24 hours post-operative
Cardiac disorders
Bradycardia
0.00%
0/4 • Pre-operative, intra-operative and first 24 hours post-operative
0.00%
0/46 • Pre-operative, intra-operative and first 24 hours post-operative
4.0%
2/50 • Number of events 2 • Pre-operative, intra-operative and first 24 hours post-operative

Additional Information

Dr. Olakunle I. Makinde

Federal Medical Centre, Yenagoa

Phone: 08032136315

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place